Workflow
益丰药房: 益丰药房第五届董事会第二十次会议决议公告

Group 1 - The board meeting of Yifeng Pharmacy Chain Co., Ltd. was held on August 14, 2025, with all nine directors present and no dissenting votes [1][2] - The board unanimously approved all agenda items during the meeting, indicating strong consensus among the directors [1][2] - The company plans to apply for a bank credit limit for its wholly-owned subsidiary, Hubei Yifeng Pharmacy Chain Co., Ltd., with the credit limit being subject to bank approval and available for revolving use [2] Group 2 - The meeting was convened by Chairman Gao Yi and followed legal and regulatory procedures, ensuring the validity of the resolutions made [1] - The decision to waive the notice period for the board meeting was made due to the urgency of the matters being discussed [1] - The proposal for bank credit will be submitted for shareholder approval in the upcoming meeting [2]